DLA Piper has advised Gilde Healthcare regarding the investment in Tromp Medical
Headquartered in the Netherlands and with subsidiaries in the Netherlands, Denmark, Spain, France, Sweden, Belgium, Finland, Norway, and Czech Republic, Tromp Medical specializes in installing and maintaining various medical imaging equipment modalities such as mammography, CT, MRI, and ultrasound systems from leading, highly innovative manufacturers, including Canon Medical Systems, Carestream, Hologic and Ziehm Imaging, with a footprint of 7,000+ systems installed.
Gilde Healthcare is a specialized healthcare investor managing over EUR 2.6 billion across two fund strategies: Venture&Growth and Private Equity. The Venture&Growth fund of Gilde Healthcare invests in fast-growing companies active in digital health, medtech, and therapeutics based in Europe and North America. The Private Equity fund of Gilde Healthcare participates in profitable lower mid-market healthcare companies based in North-Western Europe.
Gilde Healthcare is investing in Tromp Medical alongside Capital A Investment Partners to accelerate international growth in the medical imaging market. The investment was signed on 2 December 2024, and Gilde Healthcare expects to complete it later this year.
A global DLA Piper team with Karsten Pedersen and Andreas Egeblad Arendt leading the Danish parts of the transaction has advised Gilde Healthcare on this investment. Thanks to Ludo Suykerbuyk and Hugo de Bruin from Gilde Healthcare, as well as the global DLA Piper lead Jochem Beurskens, Flip Kaptein, Saar Vinke, Jean-Paul Dresen, Ilse Lagerweij and Léa Verdoodt from DLA Piper NL, for a great collaboration on this investment.
Read the press release from Gilde Healthcare here.
